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Global Curriculum in Surgical Oncology 
I. INTRODUCTION:  
The global cancer burden is expected to increase significantly over the next few decades. 
Worldwide in 2012 there were 14.1 million new cancer cases, 8.2 million cancer-related deaths 
and 32.6 million people living with cancer within five years of diagnosis.[1] It is predicted that 
by the year 2035 there will be 23.9 million new cancer cases and 14.6 million cancer-related 
deaths.[1] (Figure 1) 
The distribution of global cancer burden is and will continue to be very uneven with the majority 
afflicting the less developed regions of the world. In 2012, 5.3 million (65%) new cancer cases 
and 15.6 million (48%) cancer-related deaths (15.6 million- 48%) occurred in the less developed 
regions of the world.[1] Similarly, by 2035, 14.7 million (61%) new cancer cases and 10.3 
million (70%) cancer-related deaths will occur in the less developed regions of the world.[1] 
Nearly 80% of cancer patients will need surgical intervention at some time and by the year 2030 
it is estimated that 45 million surgical procedures will be required annually.[2] It is well known 
that the majority of patients with a cancer diagnosis do not have ready access to safe and or 
affordable cancer surgery. [2],[3] The failure to provide adequate cancer surgery can lead to a 
loss of US $ 6.2 trillion in cumulative worldwide gross domestic product by 2030.[2] While the 
causes are multi-factorial, one factor impeding access to safe and affordable cancer surgery is the   
paucity of surgeons who are trained and educated in the management of patients with varying 
cancer diagnoses. 
The ability to develop a sustainably adequate surgical oncology workforce depends on the 
presence of robust educational systems that promote training in all oncologic domains and also 
help in maintaining competency for those in clinical practice. Undoubtedly, there are significant 
differences in cancer burden, cancer types, resource-availability, oncologic management and 
even in the definition of oncologic workforce in different parts of the world. However, the fight 
against cancer is global and any effort aimed at finding uniformity in the global management of 
cancer would be of tremendous benefit to the world-wide community.  We believe that this starts 
with generating broad uniform guidelines on the training and maintenance of competency for 
surgical oncology professionals.  
 
There are several barriers to cancer care ranging from lack of cancer awareness and cultural 
barriers to presentation, lack of affordable basic population health care provisions, dearth of 
adequate facilities and inadequate number of trained personnel. Whilst it is inevitable that in 
certain countries inadequate training may be just one of many complex factors acting as barriers 
to adequate cancer care, having a globally accepted gold standard for minimal training in 
surgical oncology will help to disseminate best practice and raise global average standards of 
care and reduce inequalities. 
The aim of this position statement is to build on and harmonize our previous respective society 
training curriculae and requirements [4-6] and thereby to provide a foundational scaffolding for 
essential and common requirements for training surgical oncology professionals. The authors are 
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aware that the training of surgical oncologists worldwide is extremely variable[7] and provide a 
broad schema of the training pathway. (Figure 2) The position statement is not intended to 
mandate specific content for training for each region or country of the world. It is hoped that this 
scaffolding of essential requirements will be used as an aspirational framework upon which to 
make modifications to suit the needs of the specific region or country of the world in the future. 
It is deliberately designed to be modular and flexible to permit adaptation to the disease burden 
variations and the cultural and health economic realities of diverse countries. The authors are 
deeply aware of the diverse barriers to education in different parts of the world based on the 
socio-cultural, geo-political and financial constraints. Hence the paper does not purport to be all 
encompassing but instead focuses on the salient aspects of training that are essential to be 
incorporated into the training curriculum of a surgical oncologist. A summary of the curriculum 
is depicted in Table 1.  
II. CORE DOMAINS OF GENERAL ONCOLOGY FOR THE SURGICAL 
ONCOLOGIST:  
 A surgical oncologist is an oncologist who also possesses the expertise to perform 
operative procedures and interventions. As such, every surgical oncologist should possess 
the required knowledge of the basic principles and tenets of oncology. These are outlined 
below.  
 
1. The epidemiology of cancer which should include:   
a. A good understanding of the current and future global cancer burden and a 
GHWDLOHGXQGHUVWDQGLQJRIWKHFDQFHUGHPRJUDSK\RIWKHVXUJHRQV¶RZQ
specialist area of practice in their geographical location.   
b. Knowledge of the temporal trends in cancer incidence rates and the 
underlying causes and their likely impact on service provision.   
c. A good understanding of all modifiable and fixed risk factors and how these 
may be used to determine cancer risk in an individual patient.   
d. Should be able to provide individual and population advice in risk reduction 
strategies. 
2. Principles of screening for cancer which should include: 
a. Awareness of the essential criteria of Wilson and Junger[8] for effective 
screening, (1968), the types in use both globally and in their geographic area 
and the evidence on which their efficacy is based.   
b. Knowledge of the risks and benefits of screening in terms of screening harms 
and over-diagnosis, health economic issues (at both national and international 
levels) and a critical appreciation of the various biases associated with 
screening data interpretation which make judging its efficacy so challenging 
(lead time bias, length bias etc)[9].   
c. An understanding of the various types of screening that should include those 
of proven efficacy: breast, cervical, colorectal and gastric as well as those 
where efficacy is uncertain and trials are in progress: prostate, lung and 
ovarian cancer. 
3. Principles of chemotherapy for cancer management which should include: 
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a. A basic understanding of the general mechanism of action of key 
chemotherapy agents and their side effects, risks, benefits, indications for use 
and duration of administration in the neo-adjuvant/adjuvant and metastatic 
and palliative settings. 
b. Knowledge of how to sequence chemotherapy with other treatment options 
such as surgery and radiation therapy. 
c. Knowledge of the influence of chemotherapy on outcomes of subsequently 
performed operative procedures. 
d. Knowledge of the principles underlying single agent regimens or poly-
chemotherapy with established criteria to assess response to chemotherapy 
(response evaluation criteria in solid tumours,  RECIST etc [10]). 
e.  Awareness of the side effects and how they may be managed (for example 
neutropenic sepsis and the role of colony granulocyte stimulating factor and 
antibiotic therapy).   
f. A good understanding of the methodological issues involved in chemotherapy 
trial design and reporting to enable new trial data to be critically evaluated. 
4. Principles of radiation therapy for cancer management which should include:  
a. An understanding of the different modalities of radiation (protons, gamma, 
beta and alpha particles) and the different modes of delivery, (external beam, 
intensity modulated radiotherapy (IMRT), tomotherapy, brachytherapy, 
stereotactic radiosurgery and radiopharmaceuticals).  
b. Knowledge of how to sequence radiation therapy with other treatment options 
such as surgery and chemotherapy. 
c. Knowledge of the risks, benefits, indications for use and duration of 
administration in different cancer types in the neoadjuvant/adjuvant and the 
metastatic and palliative settings.   
d. An understanding of the biological basis of radiation induced cytotoxicity, and 
the barriers and facilitators to efficacy (radiosensitisers, hypoxia).   
e. Knowledge of the acute and longer term side effects such as acute 
inflammation, chronic radiation fibrosis and secondary cancer development 
(for example the risk of angiosarcoma) and endarteritis obliterans.   
f. Understanding of the impact of radiotherapy on the technical aspects of the 
proposed operative procedure and its subsequent morbidity (wound 
healing/dehiscence, fibrosis etc).  
5. Principles of the biologic and immunologic basis of cancer management and control 
which should include:  
a. This should include an understanding of the newer biological agents and 
targeted therapies.   
b. Understanding the basic principles of monoclonal and small molecular 
targeting agents and the principles behind their specificity in a particular 
cancer (e.g. Her-2 over expression in breast cancer, K-ras in colorectal cancer 
etc).   
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c. Knowledge of basic principles of immunotherapy (immune editing etc), novel 
immune-therapeutic agents including check-point inhibitors, their indications, 
combination strategies and their therapeutic potential. 
d. Knowledge of the health economic implications of these agents and how this 
must be taken into account by health care funders.   
e. Awareness of the common side effects of these agents. 
6. Principles of chronic pain management for cancer patients which should include:   
a. Knowledge and applied skills in the use of commonly prescribed oral, 
systemic and topical analgesics and management of untoward side effects. 
b. Knowledge of variations in pain management depending on the clinical setting 
(curative versus palliative). 
c. Knowledge of side-effects of commonly used analgesics and their 
management. 
d.  Awareness of the µDQDOJHVLF ladder¶ (proposed by the World Health 
Organization[11]) ranging from mild analgesics to strong opiates and the use 
of alternative analgesics and adjuncts such as anti-inflammatories, agents that 
are active against neuropathic pain, synthetic cannabinoids and muscle 
relaxants.  
e. Awareness of the role of local/regional blocks and other interventional 
procedures (intra-thecal pain pumps, radiofrequency ablation etc) and their 
indications and contraindications.   
f. Knowledge of the use and efficacy of transcutaneous electrical nerve 
stimulation, (TENS), acupuncture and other region-specific modalities to treat 
pain.   
7. Principles of palliative care for cancer management which should include:    
a. An deep understanding of end of life care and advance directives, living wills, 
psychological support, bereavement support and the phases of bereavement. 
b. Knowledge of palliative symptom control (anti-emetics, anti-diarhoeals, 
laxatives, appetite stimulants, nutritional support, management of pain, 
dyspnea, cough, xerostomia, excessive oral and pharyngeal secretions, fever, 
anxiety, insomnia, delirium, palliative sedation at end of life and  palliative 
surgery (for example for relief of biliary or ureteric obstruction) and steroids 
to reduce cancer related oedema (liver metastases, brain metastases).   
c. Knowledge of the use of palliative chemotherapy and radiotherapy and the 
delicate balance between symptom palliation and treatment side effects 
(Quality adjusted time without symptoms or toxicity, Q-TWIST[12]). 
d. Ability to coordinate care with multiple teams and family members to lead 
end-of-life discussions 
8. Principles of medical imaging for cancer management which should include:    
a. Knowledge of the various radiological modalities (Ultrasound, CT, MRI, PET 
CT etc) and their basic functioning principles. 
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b. Knowledge of adequate staging protocols (organ-specific protocols with 
multiple phases) for the main cancer types and the indications for each 
imaging modality in cancer assessment and operative planning.   
c. Knowledge of the indications for radiological imaging in cancer surveillance. 
d. Awareness of the use of imaging intra-operatively for margin assessment and 
cancer localization.   
e. Knowledge of the methods used to analyze pre-operative imaging to help with 
operative decision making (stereotactic localization etc). 
f. Knowledge of the use of interventional radiology in cancer care such as stent 
placement, radiotherapy, cryotherapy and high frequency ultrasound targeting, 
therapeutic vascular embolization and chemotherapy delivery.  
g. Awareness of novel imaging modalities (example: choline PET scan etc). 
h. Awareness of adverse effects associated with excessive or unwarranted 
imaging 
9. Principles of multi-disciplinary cancer management which should include:   
a. An understanding of the importance of the multi-disciplinary team (MDT) in 
the management of cancer. Optimal outcomes are delivered by multimodal 
therapy regimes which mandate that cancer decision making should be 
undertaken by a multidisciplinary team comprising a core membership of 
surgeon, pathologist, radiologist, oncologists and patient advocate.   
b. At the basic level, a MDT should help in confirming the diagnosis of cancer 
by checking concordance between the clinical, radiological and pathological 
findings before treatment commences.  
c. Knowledge of how to develop and implement HIILFLHQW0'7¶VIRU
malignancies involving various organ systems. 
10.  Principles of diagnostic pathology for cancer management which should include: 
a. Understand the role of the pathologist as part of the multidisciplinary team. 
The surgical oncologist should have a working knowledge of the following 
concepts: surgical specimen orientation, margin assessment, specimen 
preservation, standard pathology reporting and terminology, interpretation of 
frozen section reports and impact on operative planning, 
immunohistochemistry, genetic analysis techniques such as fluorescence in 
situ hybridization (FISH) and polymerase chain reaction (PCR) and more 
complex multigene array technologies.   
b. Knowledge of specimen procurement for analytical and research purposes. 
c. Knowledge of the importance of pathology in both prognosis calculation (and 
use of prognostic scoring algorithms) and in determining tumour molecular 
phenotype to guide targeted therapies (e.g. Her-2 receptor status in breast 
cancer, K-ras status in colorectal cancer, c-kit in gastrointestinal stromal 
tumours, GIST). 
d. Proficient knowledge of the commonly used pathologic staging systems for 
various cancers, such as the Tumour, Nodes, Metastases system (TNM) [13]. 
11.  Principles of surveillance for cancer management which should include: 
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a. Knowledge of post-treatment surveillance protocols for different tumour 
types, algorithms,  frequency and the evidence for benefit 
12. Principles of cancer biology which should include: 
a. This should include a basic understanding of the µhallmarks of cancer¶ 
(Hanahan and Wienberg, [14, 15]) and the processes that are key to cancer 
development and progression (angiogenesis, unregulated proliferation, 
telomere function, apoptosis, cell cycle regulation, defective DNA repair 
mechanisms, tumour initiation, promotion, migration and metastasis).   
b. Knowledge of the key oncogenes and tumour suppressor genes known to be 
implicated in the process of oncogenesis (WSUDVP\FHWF.QXGVRQ¶VWZR
hit hypothesis[16].  
c. Understanding the role of hereditary factors in carcinogenesis and the key 
cancer syndromes (BRCA, Li Fraumeni syndrome, APC, HNPCC, e cadherin 
etc).  
13. Principles of research into cancer which should include:  
a. An understanding of basic science research, translational research,  
investigating new targets for cancer therapy research, epidemiology research, 
cancer burden research, disparities research, cohort and case control study 
design and their indications and potential limitations, randomized trial design 
and quality standards, psycho-oncology research and research into quality of 
life issues.   
b. An understanding of the basic and (optionally) advanced statistical methods is 
essential to conduct research and also permit critical evaluation of research.  
14. Principles of delivering cancer care across all resource settings which should 
include:  
i. A basic understanding of the health care expenditure for the world and for 
their specific region or country. 
ii. The influence of resources (public and private) on the ability to deliver 
comprehensive cancer care. 
iii. Awareness of the influence of government policy and regulations on 
maintaining sustainable resources for delivering cancer care. 
iv. Awareness of the limitations arising out of lack of resources and the ability to 
tailor care suitable to all resource settings of the world. 
15.  Hereditary cancer syndromes and their management: 
a.  Knowledge of the role hereditary predisposition plays in the development of 
many cancer subtypes.   
b. Knowledge of management ranging from, weak predisposing genetic variants 
such as single nucleotide polymorphisms (SNPs), moderate risk genes where 
specific testing may be appropriate combined with targeted surveillance 
protocols and lastly potent genetic mutations, usually of key tumour 
suppressor genes (such as BRCA1 and 2, APC, HNPCC, tp53 etc), where not 
only targeted surveillance may be offered but risk reducing surgery may be 
appropriate.    
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c. Understanding the impact of these genes both in terms of risk estimation for 
an individual without cancer and the impact of these mutations in a patient 
with cancer on their treatment options and long term management.   
d. Knowledge of the broad indications for gene testing for at risk families.   
e. Familiarity with genetic risk calculation tools and algorithms for different 
cancer types. 
 
 
III. CORE DOMAINS IN PRE, PERI AND POST-OPERATIVE SURGICAL CARE 
FOR THE  SURGICAL ONCOLOGIST:  
 
The surgical oncologist should be technically proficient in the art, science and principles 
of surgical procedures. This should enable the surgical oncologist to perform surgical 
procedures when indicated in a safe fashion to deliver high value care with good quality 
outcomes. The surgical oncologist should therefore possess the required knowledge and 
skill of the basic principles and tenets of simple and complex oncological procedures. It 
should be emphasized that surgical care for oncology patients is provided by a wide 
variety of professionals with equally divergent training backgrounds. While in some 
countries surgical oncology training follows general surgery training, in some other 
surgical cancer care is delivered by general surgeons with no further training. Although 
some of the mentioned domains may be adequately addressed through general surgery 
training in some countries or redundant for surgical oncology training in countries with 
fellowships, the purpose of including these reflects what the finished product should be 
competent in regardless of the training pathway. These are outlined below:  
 
1. Principles of surgical procedures and techniques which include:  
a. Knowledge of the basic and complex surgical procedures for treating 
malignancies of various organ systems 
b. Knowledge of the principles of clinically relevant anatomy applicable to 
surgical procedures 
c. Knowledge of the extent of resection for primary lesions and metastatic 
lesions 
d. Knowledge of the appropriate extent of lymphadenectomy ranging from nodal 
sampling, sentinel node biopsy and different levels of lymphadenectomy for 
various cancers 
e. An understanding of how to assess margins and different levels of adequacy 
(R0, R1 and R2) 
f. Knowledge of the role of debulking surgery 
g. Awareness of the differences in the management between curative intent 
versus palliative intent surgery 
h. An understanding of the balance between oncologic adequacy versus 
minimizing morbidity and function preservation of oncological procedures. 
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2. Principles of various surgical approaches for cancer surgery. It has to be emphasized 
that the competence in this domain will be entirely dependent on the availability of 
resources which eventually determines the availability of the surgical equipment and 
required operative skills. Competence may be expected in resource-rich environments, 
whereas an awareness of the techniques is desirable in resource-poor settings. While 
technology may be available it should be evaluated in the context of each country and its 
resources ensuring that a good oncologic procedure can be performed even by the open 
approach.   
a. Competence in principles of open surgical procedures 
b. Awareness or competence in principles of minimal access procedures where 
applicable 
c. Awareness or competence in principles of  restorative, reconstructive and 
oncoplastic surgery where applicable 
d. Awareness or competence in principles of endoscopic procedures where 
applicable 
e. Awareness or competence in principles of robotic surgery where applicable 
f. Awareness or competence of natural orifice surgery and other novel 
techniques where applicable 
g. Awareness or competence in principles of interventional procedures where 
applicable. 
h. Awareness or competence in principles of ablation (radio frequency, 
microwave, cryoablation), irreversible electrophoresis etc. 
i. Awareness of newer technologies and the ability to assimilate them into 
practice where circumstances and resources permit. 
3. Principles of patient selection for cancer surgery which should include: 
a. $ELOLW\WRVHOHFWSDWLHQW¶VIRUVXUJLFDOSURFedures based on appropriate 
indications 
b. More importantly the ability to avoid surgical procedures in patients where the 
benefits are not evident 
4. Principles of risk stratification prior to surgical procedures which should include: 
a. Knowledge of how to balance risks and benefits of any proposed procedure 
b. Knowledge of some of the objective tools available to balance the risks and 
benefits prior to any surgical procedure (ACS NSQIP risk calculator[17], 
nomograms [18], regionally available quality metrics and tools etc). 
c. Knowledge of assessment of functional status based on objective tools 
(Karnofsky etc) 
d. Knowledge of subjective assessment of functional status 
e. Knowledge of how to combine objective and subjective assessments to reach 
conclusions on the risk/benefit profile for each procedure. 
5. Principles of operative planning based on staging/pre-operative imaging and 
preparation which should include:  
a. Knowledge of how to tailor operative procedures based on variations in pre-
operative staging and imaging. 
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b. Knowledge of how to tailor procedures based on functional status of patient. 
c. Awareness of pre-operative preparation such as bowel prep, when to stop anti-
coagulation etc 
6. Principles of obtaining consent for operative procedures which should include: 
a. Knowledge of how to consent that is informed and compassionate that can 
lead to shared-decision making. 
b. Ability to tailor discussions based on the complexity of the procedure. 
c. Knowledge of how to discuss the risks/benefits and pros/cons of not only 
operative procedures but also the alternatives to surgery. 
7. Principles of intra-operative care which should include:  
a. Knowledge of how to manage intra-operative complications such as the 
difficult airway, difficult venous access etc. 
b. Knowledge of how to manage intra-operative consequences such as carcinoid 
crisis, parathyroid crisis, thyrotoxic crisis etc. 
c. Knowledge of basic patho-physiological derangements such as 
haemodynamic instability requiring vasopressors, increasing airway pressures, 
bleeding diathesis etc. 
d. Knowledge of protocols to prevent intra-operative adverse events such as 
hypothermia, burns etc. 
e. Ability to work collaboratively with the pathologist to interpret intra-operative 
frozen sections and make appropriate decisions 
f. Ability to work collaboratively with anesthesiology to provide effective team 
care. 
8. Principles of post-operative care which should include:  
a. Awareness of major and minor post-operative complications. 
b. Awareness of frequency and time-frames of post-operative complications. 
c. Knowledge of how to prevent, diagnose and treat post-operative 
complications. 
d. Knowledge of commonly used preventative measures such as those to address 
deep venous thrombosis, stress ulcers etc.  
e. Knowledge of administration of post-operative antibiotics, duration, type and 
combination regimens 
f. Knowledge of how to treat complications such as deep venous thrombosis etc 
in the context of fresh post-operative state. 
g. Knowledge of commonly used tools to quantify post-operative complications 
(Clavien Dindo system [19], International Study Group of Pancreatic Fistula, 
Common terminology for adverse events, (v4.0 CTCAE [20]). 
h. Knowledge of how to manage drains, ostomies, feeding tubes etc in the post-
operative period. 
i. Knowledge of how to manage post-operative pain with combinations of 
systemic, oral, spinal, regional or other modalities. 
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j. Ability to coordinate post-operative care with multiple providers ranging from 
nursing, physiotherapy, occupational therapy, speech therapy, palliative care 
etc 
k. Knowledge of the local systems to help in discharge planning either to home 
or skilled nursing facility 
l. Ability to lead discussions with the patient and their family to discuss 
prognosis based on pathological staging and determining further treatment 
options. 
9. Principles of post-operative critical care which should include: 
a. Awareness of hemodynamic monitoring with basic knowledge of vasopressor 
agents 
b. Awareness of managing an intubated patient with basic knowledge of various 
ventilator modes, weaning modes and criteria for extubation. 
c. Knowledge of monitoring fluid status, resuscitation and the risks/benefits of 
various colloids and crystalloid administration. 
d. Awareness and expertise regarding nutritional support needs and routes in the 
pre, peri and post-operative period. 
 
IV. ESSENTIALS OF CORE KNOWLEDGE DOMAINS OF SURGICAL 
ONCOLOGY FOR EACH SPECIFIC DISEASE SITE:  
 
A surgical oncologist should possess in-depth knowledge of malignancies involving each 
specific disease site. These are outlined below:   
 
1. Breast:  
a) Breast imaging and image guided biopsy 
b) Benign breast disease 
c) High risk breast disease 
d) Breast cancer 
x In situ 
x Invasive 
x Locally advanced 
v. Uncommon breast tumors 
vi. Metastatic disease 
vii. Genetics in breast cancer 
viii. Surgical breast procedures 
 Partial mastectomy 
o Wire localization 
o Radioactive seed localization 
 Total mastectomy 
 Reconstruction options 
 Lymph node staging 
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ix. Multidisciplinary management 
 
2. Colorectal and anal cancer:  
a. Colon Cancer 
x Screening 
b. Rectal Cancer 
x Screening 
x Adenocarcinoma 
x Locally advanced 
x Other (Neuroendocrine,GIST) 
c. Anal Cancer 
x Squamous Cell 
x Melanoma 
d. Appendiceal 
x Adenocarcinoma 
x Carcinoid 
x Disseminated peritoneal adenomucinosis (DPAM or 
pseudomyxoma peritonei)  
e. Colorectal Cancer Syndromes 
x Polypoid, non-polypoid, other 
f. Procedural- Open, Minimally Invasive (Laparoscopic/Robotic if feasible and 
appropriate) 
x Colon- segmental, subtotal 
 Rectal 
 Low anastomosis (low anterior resection, coloanal 
anastomosis) 
 Abdominoperineal resection 
 Transanal excision/microsurgery (TEMS if feasible 
and appropriate) 
 Anal 
x Pelvic exenteration 
x Cytoreduction/ Cytoreduction plus hyperthermic 
intraperitoneal chemoperfusion (HIPEC if feasible and 
appropriate) 
 
3. Esophagus, gastric and GE junction: 
i. Esophagus 
x Adenocarcinoma 
x Squamous Cell Carcinoma 
x GIST 
ii. Stomach 
x Adenocarcinoma 
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x GIST 
x Carcinoid 
x Hereditary diffuse gastric cancer (HDGC) 
x Gastric lymphoma 
iii. Esophageal Resection- Open, Minimally Invasive (Laparoscopic/Robotic if 
feasible and appropriate) 
x Transhiatal 
x Ivor Lewis 
x McKeown three stage esophagectomy 
iv. Gastric Resection- Open, Minimally Invasive (Laparoscopic/Robotic if feasible 
and appropriate) 
x Distal gastrectomy 
x Total gastrectomy 
x Partial/wedge gastrectomy 
x Lymphadenectomy (at minimum D1 and D2) 
v. Staging- Open, Minimally Invasive (Laparoscopic/Robotic if feasible and 
appropriate) 
x Washings/cytology 
 
4. Small intestine: 
a) Adenocarcinoma 
b) Carcinoid 
c) Upper GI polyps- syndrome related and sporadic 
d) Small bowel resection plus regional lymphadenectomy- Open, Minimally 
Invasive (Laparoscopic/Robotic if feasible and appropriate) 
e) Radical duodenal (pancreatic-preserving) resection- Open, Minimally Invasive 
(Laparoscopic/Robotic if feasible and appropriate) 
f) Splenectomy for hematologic malignancy or metastatic disease- Open, Minimally 
Invasive (Laparoscopic/Robotic if feasible and appropriate) 
 
5. Pancreas:  
a. Adenocarcinoma 
b. Neuroendocrine 
c. Cystic neoplasms (Mucinous, Serous, Solid and papillary epithelial) 
d. Benign pancreatic disease 
e. Other 
g. Secondary, Lymphoma, heterotopia 
h. Resection procedures- Open, Minimally Invasive (Laparoscopic/Robotic if 
feasible and appropriate) 
x Pancreaticoduodenectomy 
x Distal, subtotal, central, total 
x Enucleation,  
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x Ampullary resection 
i. Palliative procedures- Open, Minimally Invasive (Laparoscopic/Robotic if 
feasible and appropriate) - Open, Minimally Invasive (Laparoscopic/Robotic if 
feasible and appropriate) 
x Bypass and stenting 
i. Diagnostic 
x Intraoperative ultrasound 
x ERCP 
 
6. Liver and Biliary Tract:  
a. Liver tumors 
x Benign 
x Malignant 
 Hepatocellular carcinoma 
 Secondary hepatic  
 Sarcoma 
b. Biliary tumors 
x Choledochal cysts 
x Pseudotumors 
o Stricture  
o Pancreatitis 
o 0LUL]]L¶VV\QGURPH 
x Gallbladder cancer 
x Cholangiocarcinoma 
c. Liver Procedures - Open, Minimally Invasive (Laparoscopic/Robotic if feasible and 
appropriate) 
x Biopsy and ultrasound 
x Major hepatectomy (segmentectomy, lobectomy, 
hemihepatectomy, caudate) 
x Non-anatomic hepatic resection 
x Ablation of liver lesions 
x Transplantation (where feasible) 
d. Biliary tract procedures- Open, Minimally Invasive (Laparoscopic/Robotic if feasible 
and appropriate) 
x Radical cholecystectomy with portal lymphadenectomy 
x Extrahepatic biliary ductal resection 
x Liver-directed therapies (where feasible) 
x Transcatheter arterial chemoembolization (TACE) 
x Other 
 
7. Endocrine:  
a. Thyroid mass 
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x Evaluation/Diagnosis 
x Indications and extent of surgery 
x Genetics 
x Preoperative and postoperative management 
b. Hyperparathyroidism 
x Evaluation/Diagnosis 
x Indications for surgery 
x Genetics 
x Preoperative and postoperative management 
c. Adrenal mass 
x Evaluation/Diagnosis 
x Indications for surgery 
x Genetics 
x Preoperative and postoperative management 
d. Thyroid surgery 
x Thyroidectomy 
x Central neck lymphadenectomy 
x Lateral compartment lymphadenectomy 
e. Parathyroid surgery 
x Parathyroidectomy 
a. Intraoperative PTH monitoring 
x Exploration 
f. Adrenalectomy 
x Open 
x MIS  
i. Laparoscopic (transabdominal/retroperitoneal) 
ii. Robotic 
g. Neuroendocrine 
 
8. Cutaneous Oncology: 
a. Melanoma 
x Primary 
x Regional disease 
o Nodal 
o In-transit 
x Metastatic 
b. Non-melanoma pigmented lesions and atypical-spitzoid lesions 
c. Merkel Cell Carcinoma 
d. Non-melanoma skin cancer (including unusual cutaneous neoplasms) 
e. Dermatofibrosarcoma Protuberans (DFSP) 
f. Wide excision/closure/reconstruction options 
g. Sentinel lymph node biopsy 
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h. Inguinal-Inguinopelvic lymphadenectomy 
i. Axillary dissection 
j. Modified radical neck dissection inclusive of parotidectomy 
k. Popliteal and epitrochlear dissections 
l. Isolated regional therapy (perfusion and infusion) 
 
9. Sarcoma:  
a. GIST 
b. Retroperitoneal, pelvic, and abdominal visceral sarcoma 
c. Extremity and trunk sarcoma 
x Sarcomas with potential lymphatic spread 
x Desmoid/aggressive fibromatosis 
x Schwannoma/Malignant peripheral nerve sheath tumors 
x DFSP-see cutaneous oncology 
d. Bone sarcoma 
e. Site-specific sarcoma 
x Uterine 
x Breast 
x Head and neck 
x Chest wall 
f. Resections 
x Limb salvage principles 
x Wide excision 
x Radical resection 
x Amputations 
x Isolated regional therapy (ILP and ILI) 
g. Advanced sarcoma 
i. Systemic/targeted therapy 
ii. Surgery for metastatic disease 
10. Peritoneal surface malignancies: 
x Appendiceal 
x Ovarian 
x Pseudomyxoma peritoneii 
11. Thoracic: 
a. Esophageal- see Upper GI 
b. Pulmonary  
x Primary lung 
x Metastatic disease 
c. Mediastinal tumors and malignant pleural effusions 
d. Procedural- Minimally invasive (thoracoscopic/laparoscopic, robotic) if feasible and 
appropriate 
x Esophageal- see Upper GI 
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x Lung procedures 
o Resection metastatic disease 
o Wedge resection/segmentectomy/lobectomy 
x Mediastinoscopy 
x Thoracoabdominal resection 
e. 'LDJQRVLVDQGPDQDJHPHQWRI%DUUHWW¶V(VRSKDJXV 
f. Palliative procedures 
 
12. Genitourinary: 
a. Renal cell carcinoma 
b. Prostate cancer 
c. Bladder cancer 
d. Testicular cancer 
e. Procedures - Minimally invasive (laparoscopic, robotic) if feasible and appropriate 
i. Radical and partial nephrectomy 
ii. Prostatectomy (as part of exenteration) 
 
13. Other malignancies involving gynecological organs 
 
14. Pathology: 
a. Tumor processing 
 Gross assessment 
 Margin assessment 
 Lymph node harvest and assessment 
 Intraoperative assessment 
x Frozen section 
x Touch cytology preparations 
 Sentinel node processing and assessment 
 Cytopathology 
 
 
V. ESSENTIAL TRAINING CORE COMPETENCIES THAT NEED TO BE 
SATISFIED:   
 
1. Holistic patient care 
A surgical oncologist should be able to provide patient care that is evidence-based, wholly 
compassionate and comprehensive to address all the multiple afflictions arising from the cancer 
diagnosis. The primary purpose of cancer care is to enhance the holistic well-being of the patient.  
Whilst the inevitable focus is on cure of the cancer, this must be dispensed in a way that preserves or 
enhances quality of life and the patienW¶VSK\VLFDODQGPHQWDOZHOO-being. The basic tenet of cancer 
FDUHVKRXOGUHO\RQ³DGGLQJOLIHWR\HDUVDQGQRW\HDUVWROLIH´ 
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Surgical oncologists have a professional duty to maintain and continually update their expertise to 
enable them to offer patient care that maximizes beneficial outcomes within the limits of the health 
care environment in which they practice.  Cancer patients are extremely vulnerable during their 
treatment phase and a surgical oncologist should be able to work with multidisciplinary teams to 
address the personal needs and preferences of patients when making treatment choices. 
2. Medical knowledge 
A surgical oncologist should possess the required medical knowledge that encompasses the entire 
spectrum ranging from aetiology, risk factors, diagnosis, treatment and surveillance. Medical 
knowledge is in a phase of rapid and sustained evolution with nearly 2 million scientific papers 
published annually. It is the obligation of the surgical oncologist to stay abreast of the current, new 
and novel knowledge domains. The surgical oncologist should strive to acquire knowledge of other 
specialties that comprise a multi-disciplinary team.  
3. Professionalism 
Professionalism is a holistic construct resting on the provision of delivering good care, demonstrating 
honesty, maintaining ethical standards, displaying respect and sensitivity to diverse cultures and 
serving as a good role model. The reputation of oneself and the profession must be maintained by 
working with the highest levels of probity and quality of care.  The confidentiality of the patient must 
be respected at all times with reference to the national legal frameworks for data protection.   The 
surgical oncologist must take responsibility for their actions and outcomes with honesty and a desire 
WRFRQWLQXDOO\LPSURYHDOZD\VSXWWLQJWKHSDWLHQW¶VQHHGVILUVW3URIHVVLRQDOLVPLVQRWMXVWWKH
province of the individual surgeon but of the health care provider organization which has a duty to 
provide a professional working environment that supports these goals. [21]  
4. Inter-professional team working and communication skills 
The surgical oncologist should demonstrate the ability to work with multi-disciplinary teams that 
stretch across disciplines and professions in a respectful manner that foster positive team dynamics. 
The leading role of the Surgical Oncologist is based on a profound and respectful understanding of all 
involved professionals. The decision-making process will benefit from scientific knowledge, clinical 
experience and compassionate insight provided by the whole team.  
The surgical oncologist should also possess communication skills that are based on empathy, 
openness and honesty. Excellent communication skills are required to not only communicate with 
other professionals but also patients and their family members. Communication with other 
professionals is based on equity, respect and sharing medical knowledge. Communication with 
families and relatives is based on honesty and the translation of complex medical knowledge into lay 
terminology to help with shared decision making. It is essential to acknowledge that communication 
is a two way process and the views and opinions of patients are respectfully incorporated in all key 
management decisions.  
5. Experiential learning 
The surgical oncologist should be able to learn from their own experiences and implement measures 
to improve outcomes. This starts with a critical assessment of their own outcomes, relative to 
nationally established benchmarks and implement individual or system-wide measures to address 
areas of deficiency. 
Since Surgery is a craft discipline, learning from critical self- assessment cannot be accomplished 
solely in a didactic learning environment but requires hands on training.  This may be provided within 
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the clinical environment with supervised training but also by use of simulation training which is 
especially valuable for the acquisition of early phase skills [22].  Unlike knowledge retention which is 
readily tested by written examination, higher level skills on 0LOOHU¶V3\UDPLGIRUWKHDVVHVVPHQWRI
clinical competencies (knowledge, competence, performance, action[23]) require more complex 
methods of assessment such as OSCE type assessments and a range of work-place based 
assessments[24-26].  Training should not be based entirely around a time frame or minimum 
numbers- based system but on a competency based system.   
In addition to a structured quality assured training program, outcomes must also be quality assured 
throughout a surgeon¶s career.  Cancer units must have robust protocols which are updated regularly 
in line with national and international guidelines and these must be audited against, both at unit level 
and at surgeon level.  This must not be done as part of a blame culture but as part of the process of 
constructive feedback to facilitate constant improvement.  The role of audit or outcomes research in 
improving cancer care is widely proven to be effective in improving outcomes[27] 
6. Systems based practice (focus on cost/value of health care delivery and quality and safety of 
health care delivery) 
As the complexity of health care delivery has increased, a surgical oncologist must understand the 
different settings of health care ranging from individual practices, group practices, stand-alone clinics, 
community health care centers to academic centers and how they relate to the larger context of health 
care delivery for their respective region or nation. 
The surgical oncologist should possess knowledge of the geo-political situation, social stability and 
health policies and regulations that can influence health care. In addition an understanding of the 
gross domestic product spent on health care and the costs of delivering patient care at an individual 
level is essential. All surgical oncologists must demonstrate an awareness of and responsiveness to 
the larger context and system of health care, as well as the ability to call effectively on other resources 
in the system to provide optimal health care. Some of the key steps are to coordinate patient care 
within the health care system, incorporate considerations of cost awareness and risk-benefit analysis 
in patient care, advocate for quality patient care and optimal patient care systems, work in inter-
professional teams to enhance patient safety and improve the quality of patient care, participate in 
identifying system errors and implementing potential systems solutions.  
7. Operative skills for surgical professionals 
The surgical oncologist should possess technical skills to be able to perform operative procedures 
safely whilst adhering to the established oncologic principles and deliver acceptable peri-operative, 
short-term and long-term oncologic outcomes.  
Embracing WKH³DUWRIVXUJHU\´LVDOLIH-long process which rests on dedication, dexterity, intuition, 
and good tuition. With a rapidly growing number of new techniques and a mounting variety of 
innovative instrumentations, a dedicated Surgical Oncologist should constantly aim to update their 
operative skills and repertoire. This continuous process benefits from extensive reading of the rapidly 
evolving relevant literature, attending scientific meetings (either physical or virtual) and participation 
in skills-based workshops.  
Hands-on learning is crucial to surgical practice: therefore surgeons are encouraged to visit expert 
colleagues who should be willing to share their advanced knowledge. Numerous fellowships are 
available to serve this purpose; the SSO and ESSO have established training programs and bursaries 
to facilitate and promote practical education. 
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8. Understanding of the Human/Compassionate side of Medicine applicable to all socio-
economic and diverse cultural regions of the world 
Medical and surgical practice are often associated to evidence-based standards and hard science in 
search of advanced cancer treatments. In reality, the practice of Surgical Oncology is both an art and a 
science: at the moment it represents the most effective practice of healing cancer patients. Patients are 
at the very center of the art of compassionate care when social interaction is combined with medical 
science. 
Geographical, cultural, economic, religious and ethical issues may differ substantially and patients 
expectations vary accordingly. Treatment availability is distributed unevenly and so is cancer 
awareness and access to diagnostic/screening tests. Such differences should be taken into account 
when setting the foundation of a Surgical Oncology program. The mission of a Surgical Oncologist is 
focused on patient well-being within the context of his or her psychosocial environment. 
 
 
VI. CONCLUSIONS AND FUTURE:  
In summary, the aim of this position statement is to provide a foundational scaffolding of 
UHTXLUHPHQWVIRUWUDLQLQJVXUJLFDORQFRORJLVW¶VJOREDOO\7KLVFXUULFXOXPLVQHLWKHUDOO- 
inclusive or all-encompassing and may not be equally applicable to all countries or regions of 
the world. It is likely that some modules of the curriculum could be redundant for some 
regions whereas some modules could be out of the reach or not applicable to others. The 
authors and their respective societies are acutely aware that the educational environment, 
training structure and pathways and regulations are extremely variable across the world. 
Similarly various social, cultural and economic factors can have a strong influence on the 
educational environment for surgical oncologists.  Despite these enormous differences, the 
foundational requirements for training a surgical oncologist globally to provide optimal 
cancer care are uniform. It is therefore envisioned that this initial position statement will 
provide a flexible and modular scaffolding that can be tailored by individual countries or 
regions to train surgical oncologists that are suitable for practice in their local environment.  
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